Absorption, distribution, metabolism, and excretion tactics toward the expedited discovery and development of the severe acute respiratory syndrome coronavirus-2 main protease inhibitor nirmatrelvir.

Paxlovid (nirmatrelvir/ritonavir) - Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/41558303

Alyssa L Dantonio; Amit S Kalgutkar; Britton Boras; Eugene P Kadar; Gregory S Walker; Heather Eng; Li Di; R Scott Obach

Jan 21, 2026